Is CME Group Stock Outperforming the S&P 500?
/CME%20Group%20Inc%20Chicago%20office-by%20JHVEPhoto%20via%20iStock.jpg)
CME Group Inc. (CME), headquartered in Chicago, Illinois, operates contract markets for the trading of futures and options on futures contracts. Valued at $95.6 billion by market cap, it offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, metals, and more. It facilitates trading on its trading floors, electronic platform, and through privately negotiated transactions that it clears.
Companies worth $10 billion or more are generally described as “large-cap stocks.” CME effortlessly fits that bill, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the financial data & stock exchanges industry. CME cements its leadership in the derivatives market with a diverse range of trading products across interest rates, equity indexes, foreign currencies, and commodities. This broad portfolio attracts a wide customer base, granting exclusive rights to trade and clear S&P futures contracts, further solidifying its competitive advantage.
Despite its notable strength, CME slipped 7.4% from its 52-week high of $290.79, achieved on Jun. 2. Over the past three months, CME stock has declined 4.6%, underperforming the S&P 500 Index’s ($SPX) 8% gains during the same time frame.

In the longer term, shares of CME rose 16% on a YTD basis and climbed 26.7% over the past 52 weeks, outperforming SPX’s YTD gains of 9.6% and solid 16.6% returns over the last year.
To confirm the bullish trend, CME has been trading above its 200-day moving average over the past year. However, the stock has been trading below its 50-day moving average since mid-August.

CME's strong performance was driven by improving revenues, primarily due to an increase in clearing and transaction fees, as well as higher fees for market data and information services. Increased market volatility also boosted volumes, contributing to the company's positive quarterly results.
On Jul. 23, CME shares closed up marginally after reporting its Q2 results. Its adjusted EPS of $2.96 exceeded Wall Street expectations of $2.91. The company’s revenue was $1.69 billion, topping Wall Street forecasts of $1.68 billion.
In the competitive arena of financial data & stock exchanges, Intercontinental Exchange, Inc. (ICE) has taken the lead over CME, showing resilience with a 17.5% uptick on a YTD basis, but lagged behind the stock with 8.5% gains over the past 52 weeks.
Wall Street analysts are cautious on CME’s prospects. The stock has a consensus “Hold” rating from the 20 analysts covering it, and the mean price target of $287.28 suggests a potential upside of 6.7% from current price levels.
On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.